Confirm BioSciences Revenue and Competitors

Location

$206.8M

Total Funding

Estimated Revenue & Valuation

  • Confirm BioSciences's estimated annual revenue is currently $5.4M per year.(i)
  • Confirm BioSciences's estimated revenue per employee is $125,500
  • Confirm BioSciences's total funding is $206.8M.

Employee Data

  • Confirm BioSciences has 43 Employees.(i)
  • Confirm BioSciences grew their employee count by 16% last year.

Confirm BioSciences's People

NameTitleEmail/Phone
1
CEO Reveal Email/Phone
2
VP strategic salesReveal Email/Phone
3
Director ITReveal Email/Phone
4
Government Contact ManagerReveal Email/Phone
5
Senior Territory ManagerReveal Email/Phone
6
Third Party Logistics ManagerReveal Email/Phone
7
Senior IT ManagerReveal Email/Phone
8
Senior Operations ManagerReveal Email/Phone
9
Warehouse ManagerReveal Email/Phone
10
Sr Customer Service ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Confirm BioSciences?

As the global leader in the field of Lab Testing for Drugs of Abuse, Confirm BioSciences is committed to being on the cutting edge of offering new, service-oriented drug testing technologies. For 10 years and counting, Confirm BioSciences has helped eradicate drug abuse the world over. We deliver quality diagnostic testing solutions and OTC wellness products to major retailers, laboratory chains, workplace sites, probation offices, and schools (to name a few). Our trademarked products are sought after for being the most accurate and affordable drug test kits available: - DrugConfirm - SalivaConfirm - HairConfirm - SteroidConfirm To commemorate our 10th anniversary in business, were introducing the latest addition to our brand family, HealthConfirm, which includes a diverse line of hormone health tests for private and professional use. We are always dedicated to serving our wonderful customers. If you have questions about ordering drug tests in bulk, or would like to learn about the pros and cons of drug testing, one of our customer service representatives will be happy to assist you. Tel: 800-908-5603

keywords:N/A

$206.8M

Total Funding

43

Number of Employees

$5.4M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Confirm BioSciences News

2022-04-20 - Pregnancy Kits Market to see Huge Growth by 2027 | Abbott ...

... Alere Inc. (United States), EKF Diagnostics (United Kingdom), Cardinal Health (United States), Confirm Biosciences (United States),...

2022-04-19 - Pascal Biosciences First To File Patent For COVID-19 Antiviral Activity With CBD

... studies independently confirming CBD as having a positive impact with respect to Covid-19', stated Brian Bapty , Pascal BioSciences CEO.

2022-04-17 - Global Pregnancy Detection Kits Market Regulations and ...

Confirm BioSciences; CVS Health; Germaine Laboratories; KIP Diagnostics; Map Diagnostics; Piramal Healthcare; Philippine Blue Cross Biotech...

2020-12-09 - Confirm BioSciences Acquired by Clinical Reference Laboratory

SAN DIEGO and LENEXA, Kan., Dec. 9, 2020 /PRNewswire/ -- Confirm BioSciences, a leading provider of comprehensive screening tools and solutions, announced today that the company has been acquired by Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laborat ...

2020-09-29 - Confirm BioSciences Partners with Securiport to Offer Rapid COVID-19 Testing Capabilities to Securiport's Epidemic Control System (ECS)

SAN DIEGO and WASHINGTON, Sept. 29, 2020 /PRNewswire/ -- Confirm BioSciences, a leading provider of comprehensive medical screening tools and solutions, and Securiport, a global leader in the design and implementation of civil aviation security, border management, advanced identification, and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M435%N/A
#2
$5.2M430%N/A
#3
$4.8M43N/AN/A
#4
$5M43-4%N/A
#5
$3.5M430%$87.2M